Mycetoma is a chronic, granulomatous infection of subcutaneous tissue, that may involve deep structures and bone. It can be caused by bacteria (actinomycetoma) or fungi (eumycetoma). There is an epidemiological association between mycetoma and the environment, including rainfall, temperature and humidity but there are still many knowledge gaps in the identification of the natural habitat of actinomycetes, their primary reservoir, and their precise geographical distribution.
Knowing the potential distribution of this infection and its ecological niche in endemic areas is relevant to determine disease management strategies and etiological agent habitat or reservoirs.This was an ambispective descriptive study of 31 patients with actinomycetoma.
We determined the biophysical characteristics including temperature, precipitation, soil type, vegetation, etiological agents, and mapped actinomycetoma cases in Northeast Mexico. We identified two disease cluster areas. One in Nuevo Leon, with a predominantly kastanozems soil type, with a mean annual temperature of 22°, and a mean annual precipitation of 585.2 mm.
Herein, mycetoma cases were produced by Actinomadura pelletieri, Actinomadura madurae, Nocardia brasiliensis, and Nocardia spp. The second cluster was in San Luis Potosí, where lithosols soil type predominates, with a mean annual temperature of 23.5° and a mean annual precipitation of 635.4 mm. In this area, all the cases were caused by N. brasiliensis. A.
madurae cases were identified in rendzinas, kastanozems, vertisols, and lithosols soils, and A. pelletieri cases in xerosols, kastanozems, and rendzinas soils. Previous thorn trauma with Acacia or Prosopis plants was referred by 35.4% of subjects. In these states, the presence of thorny plants, such as Acacia spp.,
TS-152.40-514-L-RD-20 AC Signs |
|
121759 |
BRADY NV |
Pack of 20 Label(s) |
EUR 29.9 |
|
Description: Description Dutch: ToughStripe gestanste cijfers en letters; Description French: Chiffres et lettres prédécoupés ToughStripe |
TS-152.40-514-L-GN-20 AC Signs |
|
121760 |
BRADY NV |
Pack of 20 Label(s) |
EUR 29.9 |
|
Description: Description Dutch: ToughStripe gestanste cijfers en letters; Description French: Chiffres et lettres prédécoupés ToughStripe |
TS-152.40-514-L-BL-20 AC Signs |
|
121761 |
BRADY NV |
Pack of 20 Label(s) |
EUR 29.9 |
|
Description: Description Dutch: ToughStripe gestanste cijfers en letters; Description French: Chiffres et lettres prédécoupés ToughStripe |
TS-152.40-514-L-YL-20 AC Signs |
|
121762 |
BRADY NV |
Pack of 20 Label(s) |
EUR 29.9 |
|
Description: Description Dutch: ToughStripe gestanste cijfers en letters; Description French: Chiffres et lettres prédécoupés ToughStripe |
10L MAGNETIC STIRRER WITH AC MOTOR (Upto 10L) |
|
BLFHMGS01100000000 |
Borosil |
1 Unit |
Ask for price |
PMNL-ZUUR-OR3-RL70-LL AC Signs |
|
804302 |
BRADY NV |
Roll of 505 Mark(s) |
EUR 280.21 |
|
Description: Description Dutch: Leidingmerker zonder drager - Zuren; Description French: Marqueur de tuyauterie |
PMNL-ZUUR-OR4-RL70-LL AC Signs |
|
804303 |
BRADY NV |
Roll of 220 Mark(s) |
EUR 280.21 |
|
Description: Description Dutch: Leidingmerker zonder drager - Zuren; Description French: Marqueur de tuyauterie |
AC-PEG-AC |
|
abx085037-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 393.6 |
|
|
AC-PEG-AC |
|
abx085037-1kDa1g |
Abbexa |
1 kDa; 1 g |
EUR 393.6 |
|
|
AC-PEG-AC |
|
abx085037-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 393.6 |
|
|
PMNL-ZURE OPLOSSING-OR3-RL70-LL AC Signs |
|
804297 |
BRADY NV |
Roll of 505 Mark(s) |
EUR 280.21 |
|
Description: Description Dutch: Leidingmerker zonder drager - Zuren; Description French: Marqueur de tuyauterie |
PMNL-ZURE OPLOSSING-OR4-RL70-LL AC Signs |
|
804298 |
BRADY NV |
Roll of 220 Mark(s) |
EUR 280.21 |
|
Description: Description Dutch: Leidingmerker zonder drager - Zuren; Description French: Marqueur de tuyauterie |
Ac-GPK(Ac)-pNA |
|
5-00556 |
CHI Scientific |
4 x 5mg |
EUR 382.2 |
|
Description: Ac-Gly-Pro-Lys(Ac)-pNA |
Ac-Lys(Ac)-OH |
|
4025494.0001 |
Bachem |
1 g |
EUR 75.29 |
|
|
Ac-Lys(Ac)-OH |
|
4025494.0005 |
Bachem |
5 g |
EUR 299.99 |
|
|
Ac-Lys(Ac)-OH |
|
E-1775.0001 |
Bachem |
1.0g |
EUR 151.2 |
|
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5] |
Ac-Lys(Ac)-OH |
|
E-1775.0005 |
Bachem |
5.0g |
EUR 501.6 |
|
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5] |
AC-PEG-AC,10K |
|
33-HO009009-10K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,1K |
|
33-HO009009-1K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,20K |
|
33-HO009009-20K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,2K |
|
33-HO009009-2K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,3.4K |
|
33-HO009009-3.4K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
AC-PEG-AC,5K |
|
33-HO009009-5K |
Biochempeg |
-
Ask for price
-
Ask for price
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
Ac-GPK(Ac)-pNA |
|
MBS826326-5x10mg |
MyBiosource |
5x10mg |
EUR 3975 |
AC |
|
ABC-TC447S |
AcceGen |
1 vial |
Ask for price |
|
Description: Tissue: blood; Transformed by: Epstein-Barr. |
Ac-GPK(Ac)-Pna [Ac-Gly-Pro-Lys(Ac)pNA; MW:504.5] |
|
SP-52003-25 |
Alpha Diagnostics |
25 mg |
EUR 1302 |
Ac-DL-Lys(Ac)-OH |
|
F-3205.0001 |
Bachem |
1.0g |
EUR 166.8 |
|
Description: Sum Formula: C10H18N2O4; CAS# [35436-74-9] |
Ac-DL-Lys(Ac)-OH |
|
F-3205.0005 |
Bachem |
5.0g |
EUR 572.4 |
|
Description: Sum Formula: C10H18N2O4; CAS# [35436-74-9] |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
4044046.0005 |
Bachem |
5 mg |
EUR 187.64 |
|
|
Ac-Arg-Gly-Lys(Ac)-AMC |
|
4044046.0025 |
Bachem |
25 mg |
EUR 749.39 |
|
|
Ac-Gly-Ala-Lys(Ac)-AMC |
|
4060671.0005 |
Bachem |
5 mg |
EUR 187.64 |
|
|
Ac-Gly-Ala-Lys(Ac)-AMC |
|
4060671.0025 |
Bachem |
25 mg |
EUR 749.39 |
|
|
Ac-Arg-Gly-Lys(Ac)-AMC |
|
I-1925.0005 |
Bachem |
5.0mg |
EUR 327.6 |
|
Description: Sum Formula: C28H40N8O7; CAS# [660846-97-9] net |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
I-1925.0025 |
Bachem |
25.0mg |
EUR 1197.6 |
|
Description: Sum Formula: C28H40N8O7; CAS# [660846-97-9] net |
Ac-Gly-Ala-Lys(Ac)-AMC |
|
I-1975.0005 |
Bachem |
5.0mg |
EUR 327.6 |
|
Description: Sum Formula: C25H33N5O7; CAS# [577969-56-3] |
Ac-Gly-Ala-Lys(Ac)-AMC |
|
I-1975.0025 |
Bachem |
25.0mg |
EUR 1197.6 |
|
Description: Sum Formula: C25H33N5O7; CAS# [577969-56-3] |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
MBS5797770-25mg |
MyBiosource |
25mg |
EUR 1090 |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
MBS5797770-5mg |
MyBiosource |
5(mg |
EUR 325 |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
MBS5797770-5x25mg |
MyBiosource |
5x25(mg |
EUR 4765 |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
T36686-10mg |
TargetMol Chemicals |
10mg |
Ask for price |
|
|
|
Description: Ac-Arg-Gly-Lys(Ac)-AMC |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
T36686-1g |
TargetMol Chemicals |
1g |
Ask for price |
|
|
|
Description: Ac-Arg-Gly-Lys(Ac)-AMC |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
T36686-1mg |
TargetMol Chemicals |
1mg |
Ask for price |
|
|
|
Description: Ac-Arg-Gly-Lys(Ac)-AMC |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
T36686-50mg |
TargetMol Chemicals |
50mg |
Ask for price |
|
|
|
Description: Ac-Arg-Gly-Lys(Ac)-AMC |
Ac-Arg-Gly-Lys(Ac)-AMC |
|
T36686-5mg |
TargetMol Chemicals |
5mg |
Ask for price |
|
|
|
Description: Ac-Arg-Gly-Lys(Ac)-AMC |
Ac-Arg-Gly-Lys(Ac)-MCA |
|
MBS406244-1mg |
MyBiosource |
1mg |
EUR 200 |
Ac-Arg-Gly-Lys(Ac)-MCA |
|
MBS406244-5mg |
MyBiosource |
5mg |
EUR 535 |
Ac-Arg-Gly-Lys(Ac)-MCA |
|
MBS406244-5x1mg |
MyBiosource |
5x1mg |
EUR 865 |
Ac-Arg-Gly-Lys(Ac)-MCA |
|
MBS406244-5x5mg |
MyBiosource |
5x5mg |
EUR 2340 |
AC 55541 |
|
A8669-10 |
ApexBio |
10 mg |
EUR 218.4 |
|
|
|
Description: Angiogenesis|PAR1 |
AC 55541 |
|
A8669-25 |
ApexBio |
25 mg |
EUR 717.6 |
|
Description: AC 55541 is a potent agonist of PAR2 with pEC50 value of 6.7 and functions range from 200 to 1000 nM [1-3]. |
AC 55541 |
|
A8669-5 |
ApexBio |
5 mg |
EUR 132.8 |
|
|
|
Description: Angiogenesis|PAR1 |
AC 55541 |
|
A8669-50 |
ApexBio |
50mg |
EUR 939.2 |
|
|
|
Description: Angiogenesis|PAR1 |
AC 264613 |
|
A8670-10 |
ApexBio |
10 mg |
EUR 400 |
|
|
|
Description: Angiogenesis|PAR1 |
AC 264613 |
|
A8670-50 |
ApexBio |
50 mg |
EUR 1319.2 |
|
|
|
Description: Angiogenesis|PAR1 |
Ac-Pepstatin |
|
5-00564 |
CHI Scientific |
10mg |
EUR 180.18 |
|
Description: Ac-Val-Val-Sta-Ala-Sta |
Ac-Glutamine |
|
5-00569 |
CHI Scientific |
4 x 5mg |
EUR 155.61 |
|
Description: Ac-Gln |
AC 55649 |
|
B7052-10 |
ApexBio |
10 mg |
EUR 184 |
|
|
|
Description: Others|RARs |
AC 55649 |
|
B7052-50 |
ApexBio |
50 mg |
EUR 752.8 |
|
|
|
Description: Others|RARs |
AC 45594 |
|
B7252-10 |
ApexBio |
10 mg |
EUR 144 |
|
|
|
Description: Others|Nuclear Receptors |
AC 45594 |
|
B7252-50 |
ApexBio |
50 mg |
EUR 607.2 |
|
|
|
Description: Others|Nuclear Receptors |
AC 187 |
|
B5424-.5 |
ApexBio |
500 ug |
EUR 625.6 |
|
|
|
Description: GPCR/G protein|Calcitonin and Related Receptors |
9-AC |
|
B6525-100 |
ApexBio |
100 mg |
EUR 78.4 |
|
|
|
Description: Membrane Transporter/Ion Channel|Chloride Channels |
AC 261066 |
|
B7574-10 |
ApexBio |
10 mg |
EUR 456 |
|
|
|
Description: Others|RARs |
AC 261066 |
|
B7574-50 |
ApexBio |
50 mg |
EUR 1418.4 |
|
|
|
Description: Others|RARs |
ac Antibody |
|
CSB-PA318709XA01DLU-02mg |
Cusabio |
0.2mg |
Ask for price |
|
|
|
Description: Recombinant Drosophila melanogaster (Fruit fly) ac protein |
ac Antibody |
|
CSB-PA318709XA01DLU-10mg |
Cusabio |
10mg |
Ask for price |
|
|
|
Description: Recombinant Drosophila melanogaster (Fruit fly) ac protein |
ac Antibody |
|
CSB-PA325623XA01EDZ-02mg |
Cusabio |
0.2mg |
Ask for price |
|
|
|
Description: Recombinant Enterobacteria phage T4 (Bacteriophage T4) ac protein |
ac Antibody |
|
CSB-PA325623XA01EDZ-10mg |
Cusabio |
10mg |
Ask for price |
|
|
|
Description: Recombinant Enterobacteria phage T4 (Bacteriophage T4) ac protein |
mPEG-AC |
|
abx085017-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 444 |
|
|
mPEG-AC |
|
abx085017-1kDa1g |
Abbexa |
1 kDa; 1 g |
EUR 427.2 |
|
|
mPEG-AC |
|
abx085017-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 444 |
|
|
mPEG-AC |
|
abx085017-5kDa1g |
Abbexa |
5 kDa; 1 g |
EUR 427.2 |
|
|
Ac-Exatecan |
|
HY-79490 |
MedChemExpress |
10 mg |
EUR 102.82 |
|
Description: Ac-Exatecan is acetylated Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM)[1]. |
AC-7954 |
|
HY-10658 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: AC-7954 is a selective nonpeptidic urotensin receptor agonist (EC50: 300 nM at the human UII receptor)[1]. |
AC-55649 |
|
HY-108526 |
MedChemExpress |
5mg |
EUR 129.87 |
|
Description: AC-55649 is a potent, highly isoform-selective agonist of human RARβ2 receptor, with a pEC50 of 6.9. |
AC-261066 |
|
HY-108532 |
MedChemExpress |
10 mg |
EUR 887.46 |
|
Description: AC-261066 is a potent, orally available and isoform-selective retinoic acid beta2 (RARbeta2) receptor agonist, with a pEC50 of 8.0[1]. |
AC-186 |
|
HY-110157 |
MedChemExpress |
1 mg |
EUR 638.54 |
|
Description: AC-186 is a selective non-steroidal estrogen receptor β (ERβ) agonist with EC50s of 6 nM and 5000 nM for ERβ and ERα, respectively. AC-186 shows gender specific neuroprotection in a Parkinson’s Disease rat model[1]. |
AC-099 |
|
HY-154829 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: AC-099 (compound 3) is a selective NPFF2R full agonist (EC50=1189 nM) and NPFF1R partial agonist (EC50=2370 nM). AC-099 attenuates spinal nerve ligation-induced hypersensitivity in rats[1][2]. |
AC-90179 |
|
HY-117118A |
MedChemExpress |
2mg |
EUR 151.52 |
|
Description: AC-90179 is a selective 5-HT2A receptor inverse agonist (Ki = 2.1 nM) and 5-HT2C antagonist, a potential antipsychotic compound[1]. |
AC-265347 |
|
HY-117851 |
MedChemExpress |
10mg |
EUR 250 |
|
Description: AC-265347 is a calcium-sensing receptor (CaSR) agonist and positive allosteric modulator (ago-PAM) with the functional affinity (pKB) of 5.1. AC-265347 can be used for the research of hyperparathyroidism and related diseases[1]. |
AC-93253 |
|
HY-118343 |
MedChemExpress |
10 mg |
EUR 423.17 |
|
Description: AC-93253 is a selective, potent SIRT2 inhibitor. AC93253 can inhibit SIRT2 with an IC50 value of 6 μM. AC93253 can be used for the research of tumors[1]. |
AC-42 |
|
HY-118806 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: AC-42 is a poent M1 muscarinic selective allosteric agonist with EC50s of 805 nM and 220 nM for human wild-type and Y381A mutated M1 receptors, respectively[1]. |
AC-262536 |
|
HY-122025 |
MedChemExpress |
10 mg |
EUR 551.96 |
|
Description: AC-262536 is a selective and non-steroidal androgen receptor modulators (SARMs) with beneficial anabolic effects. AC-262536 exhibits potent agonist activity at the androgen receptor, with an affinity in the low nanomolar range (1-10 nM)[1]. |
AC-73 |
|
HY-122214 |
MedChemExpress |
10 mg |
EUR 703.47 |
|
Description: AC-73 is a first specific, orally active inhibitor of cluster of differentiation 147 (CD147), which specifically disrupts CD147 dimerization, thereby mainly suppressing the CD147/ERK1/2/STAT3/MMP-2 pathways. AC-73 inhibits the motility and invasion of hepatocellular carcinoma cells[1]. AC-73 is also an anti-proliferative agent and an inducer of autophagy in leukemic cells[2]. |
AC-386 |
|
HY-143463 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: AC-386 is a highly potent c-Met inhibitor with IC50 value of 7.42 nM. AC-386 has antiproliferative activities against certain cancer cell lines. AC-386 can be used for researching anti-cancer resistance[1]. |
AC-55541 |
|
HY-14350 |
MedChemExpress |
10mM/1mL |
EUR 857.16 |
|
Description: AC-55541 is a highly selective protease-activated receptor 2 (PAR2) agonist (pEC50=6.7), displays no activity at other PAR subtypes or at over 30 other receptors involved in nociception and inflammation. AC-55541 has pEC50 values of 5.9 and 6.6 in PI hydrolysis assays and Ca2+ mobilization assays and exhibits pronociceptive activity in vivo[1]. |
AC-264613 |
|
HY-14351 |
MedChemExpress |
1 mg |
EUR 113.64 |
|
Description: AC-264613 is a potent and selective protease-activated receptor (PAR-2) agonist with a pEC50 of 7.5[1]. |
AC-55541 |
|
MBS3845642-5x100mg |
MyBiosource |
5x100mg |
EUR 4825 |
Prosopis spp., Senegalia greggi, Vachellia farnesiana and Vachellia rigidula, are common.Mapping this neglectedtropical infection aids in the detection of disease cluster areas, the development of public health strategies for early diagnosis and disease prediction models; this paves the way for more ecological niche etiological agent research.